Notably, the predictive advantage of apoA-I in preβ-1 HDL over CRP was more pronounced in men (AUC difference of 0.081), suggesting that HDL functionality-related markers may provide greater discrimination of CHD risk in men compared with systemic inflammatory markers. The gene discussed is APOA1; the disease is coronary artery disorder.